z-logo
open-access-imgOpen Access
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?
Author(s) -
Giuseppe Saglio,
Carmen Fava,
Robert Peter Gale
Publication year - 2019
Publication title -
haematologica
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.214445
Subject(s) - myeloid leukemia , tyrosine kinase inhibitor , medicine , tyrosine kinase , dosing , adverse effect , cancer research , pharmacology , oncology , cancer , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom